Tianjin, China

Cunxiang Zhao

This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Avanir Pharmaceuticals. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cunxiang Zhao. Retrieved from https://idiyas.com/inventor/cunxiang-zhao-2em81des

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Cunxiang Zhao

Introduction

Cunxiang Zhao is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of deuterated compounds. With a total of four patents to his name, Zhao's work is recognized for its potential impact on drug development.

Latest Patents

Zhao's latest patents include methods for the synthesis of deuterated dextromethorphan. The application describes innovative methods for producing deuterated dextromethorphan of Formula (I), along with the deuterated dextromethorphan produced by these methods and pharmaceutically acceptable salts thereof. This work is crucial for enhancing the efficacy and safety of pharmaceutical products.

Career Highlights

Cunxiang Zhao is currently employed at Avanir Pharmaceuticals, where he continues to advance his research and development efforts. His expertise in synthetic methods has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Zhao collaborates with several professionals in his field, including Matt Johnson and Weihua Meng. These partnerships enhance the scope and impact of his research initiatives.

Conclusion

Cunxiang Zhao's contributions to pharmaceutical innovation through his patents and collaborative efforts highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in drug synthesis and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…